Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication 
Erythrosine
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/13/2021
Ethyl 3-hydroxy-6-methyl-4-[[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoate
Potential treatment - theoretical effect Experimental Antiviral Jan/12/2021
XG014
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/12/2021
Peptide #2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/11/2021
CR-31-B (-)
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/08/2021
Sar9, Met (O2)11-Substance P
Potential treatment - theoretical effect Experimental Antiviral Jan/08/2021
SΔC-Fer
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/05/2021
1-((1R)-1-(Hydroxymethyl)-3-(1-naphthyl)propyl)-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
1-[(1R)-3-(6-{[(Benzylamino)carbonyl]amino}-1H-indol-1-YL)-1-(hydroxymethyl)propyl]-1H-imidazole-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Jan/05/2021
TMC-310911
Potential treatment - theoretical effect Experimental Antiviral Jan/02/2021
ACE2‐TMPRSS2‐EVs
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/28/2020
ACE2‐EVs
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/28/2020
4'-Acetamido-4-dimethylaminochalcone
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
N-(4-[(2E)-3-(4-ethoxyphenyl)-1-(phenyl)prop-2-en-1-one]) acetamide
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
N-{4-[(2E)-3-(4-Methoxyphenyl)prop-2-enoyl]phenyl}acetamide
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
N-[4-[(E)-3-(4-Fluorophenyl)prop-2-enoyl]phenyl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
4'-Acetamidochalcone
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
Remikiren
Potential treatment - theoretical effect Experimental Antiviral Dec/24/2020
INO-4800
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2020
Gallium maltolate
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/22/2020